LENSAR (LNSR) to Release Earnings on Thursday

LENSAR (NASDAQ:LNSR) is anticipated to post its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect LENSAR to post earnings of ($0.1650) per share and revenue of $14.65 million for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 13, 2026 at 12:30 PM ET.

LENSAR (NASDAQ:LNSR) last released its earnings results on Friday, May 8th. The company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $1.38. LENSAR had a net margin of 50.94% and a negative return on equity of 183.19%. The firm had revenue of $13.43 million during the quarter, compared to analyst estimates of $13.40 million.

LENSAR Trading Up 3.7%

LNSR stock opened at $5.58 on Wednesday. The stock has a market cap of $68.52 million, a PE ratio of -9.62 and a beta of 0.89. LENSAR has a 12 month low of $4.95 and a 12 month high of $13.20. The company has a 50-day moving average price of $5.77 and a 200 day moving average price of $7.65.

Wall Street Analyst Weigh In

Several brokerages have issued reports on LNSR. Weiss Ratings upgraded LENSAR from a “sell (d-)” rating to a “sell (d+)” rating in a research report on Monday, May 11th. Wall Street Zen cut LENSAR from a “hold” rating to a “sell” rating in a report on Saturday, May 16th. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, LENSAR presently has an average rating of “Hold” and an average price target of $10.00.

Hedge Funds Weigh In On LENSAR

A number of hedge funds have recently added to or reduced their stakes in LNSR. Royal Bank of Canada increased its position in shares of LENSAR by 212.4% during the fourth quarter. Royal Bank of Canada now owns 11,277 shares of the company’s stock worth $131,000 after acquiring an additional 7,667 shares during the period. Barclays PLC raised its stake in shares of LENSAR by 10.3% during the fourth quarter. Barclays PLC now owns 14,857 shares of the company’s stock valued at $173,000 after acquiring an additional 1,389 shares in the last quarter. State Street Corp boosted its holdings in shares of LENSAR by 4.6% in the fourth quarter. State Street Corp now owns 123,720 shares of the company’s stock valued at $1,439,000 after purchasing an additional 5,470 shares during the period. Dynamic Technology Lab Private Ltd boosted its holdings in shares of LENSAR by 436.6% in the fourth quarter. Dynamic Technology Lab Private Ltd now owns 54,166 shares of the company’s stock valued at $630,000 after purchasing an additional 44,072 shares during the period. Finally, Wells Fargo & Company MN grew its stake in LENSAR by 69.4% in the fourth quarter. Wells Fargo & Company MN now owns 10,734 shares of the company’s stock worth $125,000 after purchasing an additional 4,398 shares in the last quarter. 40.15% of the stock is currently owned by institutional investors.

About LENSAR

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.